PKTX
vs
S&P 500
PKTX
S&P 500
Over the past 12 months, PKTX has underperformed S&P 500, delivering a return of -24% compared to the S&P 500's +38% growth.
Stocks Performance
PKTX vs S&P 500
Performance Gap
PKTX vs S&P 500
Performance By Year
PKTX vs S&P 500
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
ProtoKinetix Inc
Glance View
Protokinetix, Inc. is a research and development stage biotechnology company, which engages in the scientific medical research of anti-aging glycoproteins. The company is headquartered in Marietta, Ohio. The company went IPO on 2002-01-07. The firm is focused on the scientific medical research of anti-freeze glycoproteins (AFGPs) and anti-aging glycoproteins (AAGPs). The Company’s anti-aging glycopeptide is for the ophthalmology, dermatology, transplant support and biomanufacturing. The firm has not developed a commercially viable product and has not generated any revenue